Perspective Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Perspective Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Perspective Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 18.3 %, a 92% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 18.3 +8.79 +92% Sep 30, 2024
Q2 2024 17.2 +8.48 +97.8% Jun 30, 2024
Q1 2024 18.4 +11.2 +155% Mar 31, 2024
Q4 2023 13.9 +7.81 +129% Dec 31, 2023
Q3 2023 9.55 +3.97 +71.1% Sep 30, 2023
Q2 2023 8.67 +4 +85.7% Jun 30, 2023
Q1 2023 7.22 +2.72 +60.4% Mar 31, 2023
Q4 2022 6.06 +1.54 +34.1% Dec 31, 2022
Q3 2022 5.59 +0.03 +0.54% Sep 30, 2022
Q2 2022 4.67 -3.07 -39.7% Jun 30, 2022
Q1 2022 4.5 -8.4 -65.1% Mar 31, 2022
Q4 2021 4.52 -35.6 -88.7% Dec 31, 2021
Q3 2021 5.55 -46.4 -89.3% Sep 30, 2021
Q2 2021 7.73 -41.3 -84.2% Jun 30, 2021
Q1 2021 12.9 -27.9 -68.4% Mar 31, 2021
Q4 2020 40.1 +7.18 +21.8% Dec 31, 2020
Q3 2020 52 +24.3 +87.5% Sep 30, 2020
Q2 2020 49 +26.9 +122% Jun 30, 2020
Q1 2020 40.8 +15 +58.2% Mar 31, 2020
Q4 2019 32.9 +6.35 +23.9% Dec 31, 2019
Q3 2019 27.7 +2.02 +7.86% Sep 30, 2019
Q2 2019 22.1 -3.28 -12.9% Jun 30, 2019
Q1 2019 25.8 +6.76 +35.5% Mar 31, 2019
Q4 2018 26.6 +10.3 +62.8% Dec 31, 2018
Q3 2018 25.7 +11.6 +82.6% Sep 30, 2018
Q2 2018 25.4 +12.7 +101% Jun 30, 2018
Q1 2018 19 +7.62 +66.8% Mar 31, 2018
Q4 2017 16.3 +4.94 +43.5% Dec 31, 2017
Q3 2017 14.1 +2.4 +20.6% Sep 30, 2017
Q2 2017 12.6 +1.25 +11% Jun 30, 2017
Q1 2017 11.4 0 0% Mar 31, 2017
Q4 2016 11.4 +0.88 +8.39% Dec 31, 2016
Q3 2016 11.7 +1.85 +18.8% Sep 30, 2016
Q2 2016 11.4 +1.89 +19.9% Jun 30, 2016
Q1 2016 11.4 +1.84 +19.2% Mar 31, 2016
Q4 2015 10.5 +0.64 +6.5% Dec 31, 2015
Q3 2015 9.83 -1.57 -13.8% Sep 30, 2015
Q2 2015 9.49 -4.52 -32.3% Jun 30, 2015
Q1 2015 9.57 -8.32 -46.5% Mar 31, 2015
Q4 2014 9.85 -17 -63.3% Dec 31, 2014
Q3 2014 11.4 -14.8 -56.6% Sep 30, 2014
Q2 2014 14 -9.96 -41.6% Jun 30, 2014
Q1 2014 17.9 -5.68 -24.1% Mar 31, 2014
Q4 2013 26.8 +3.5 +15% Dec 31, 2013
Q3 2013 26.2 +2.35 +9.84% Sep 30, 2013
Q2 2013 24 -3.01 -11.2% Jun 30, 2013
Q1 2013 23.6 -1.7 -6.73% Mar 31, 2013
Q4 2012 23.3 Dec 31, 2012
Q3 2012 23.9 Sep 30, 2012
Q2 2012 27 Jun 30, 2012
Q1 2012 25.3 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.